Carla Caramella Selected Research

Skin Ulcer

1/2017	Application of DoE approach in the development of mini-capsules, based on biopolymers and manuka honey polar fraction, as powder formulation for the treatment of skin ulcers.
7/2016	Particulate systems based on pectin/chitosan association for the delivery of manuka honey components and platelet lysate in chronic skin ulcers.
3/2016	Sponge-Like Dressings Based on the Association of Chitosan and Sericin for the Treatment of Chronic Skin Ulcers. I. Design of Experiments-Assisted Development.
3/2016	Sponge-Like Dressings Based on the Association of Chitosan and Sericin for the Treatment of Chronic Skin Ulcers. II. Loading of the Hemoderivative Platelet Lysate.
2/2014	Montmorillonite-chitosan-silver sulfadiazine nanocomposites for topical treatment of chronic skin lesions: in vitro biocompatibility, antibacterial efficacy and gap closure cell motility properties.
1/2014	Calcium alginate particles for the combined delivery of platelet lysate and vancomycin hydrochloride in chronic skin ulcers.
1/2007	Wound dressings based on chitosans and hyaluronic acid for the release of chlorhexidine diacetate in skin ulcer therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carla Caramella Research Topics

Disease

12	Wounds and Injuries (Trauma) 09/2019 - 01/2007
7	Skin Ulcer 01/2017 - 01/2007
3	Infections 11/2014 - 01/2008
2	Hemorrhage 09/2019 - 03/2018
2	Mucositis 03/2014 - 09/2011
1	Inflammation (Inflammations) 01/2019
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 08/2017
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2016
1	Arthritis (Polyarthritis) 10/2015
1	Ulcer 04/2012
1	Drug-Related Side Effects and Adverse Reactions 06/2011

Drug/Important Bio-Agent (IBA)

11	ChitosanIBA 09/2019 - 01/2007
5	Pharmaceutical PreparationsIBA 08/2017 - 01/2008
5	PowdersIBA 01/2017 - 01/2014
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 02/2011
4	Silver Sulfadiazine (SSD)FDA LinkGeneric 02/2018 - 05/2013
3	Glutamic Acid (Glutamate)FDA Link 02/2018 - 05/2013
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2014 - 03/2012
2	PolymersIBA 09/2019 - 01/2007
2	AntioxidantsIBA 02/2018 - 01/2007
2	Sericins (Sericin)IBA 03/2016 - 03/2016
2	Excipients (Suspending Agents)IBA 01/2016 - 06/2011
2	Ophthalmic Solutions (Eye Drops)IBA 01/2016 - 04/2012
2	Hyaluronic Acid (Hyaluronan)IBA 10/2015 - 01/2007
2	Vancomycin FDA LinkGeneric 01/2014 - 01/2008
1	Tranexamic Acid (AMCA)FDA Link 09/2019
1	Nasal SpraysIBA 09/2019
1	SolutionsIBA 09/2019
1	Peptide Hydrolases (Proteases)FDA Link 01/2019
1	alpha-Tocopherol FDA Link 02/2018
1	Sulfadiazine (Sulphadiazine)FDA Link 02/2018
1	Oleic Acid (Oleate)IBA 02/2018
1	Tocopherols (Tocopherol)IBA 02/2018
1	VaccinesIBA 08/2017
1	Peptides (Polypeptides)IBA 08/2017
1	Anti-Infective Agents (Microbicides)IBA 08/2017
1	Biopolymers (Biopolymer)IBA 01/2017
1	OligosaccharidesIBA 01/2017
1	PectinsIBA 07/2016
1	Phosphates (Orthophosphate)IBA 03/2016
1	Poloxamer (Poloxamer 407)IBA 03/2014
1	GlycerophosphatesIBA 03/2014
1	GelsIBA 03/2014
1	chitosan lactateIBA 03/2014
1	AlginatesIBA 01/2014
1	platelet-derived growth factor ABIBA 01/2014
1	CelluloseIBA 05/2013
1	Silver CompoundsIBA 05/2013
1	Lipid NanoparticlesIBA 05/2013
1	UCON 50-HB-5100 (F127)IBA 09/2011
1	carbopol 940 (sodium polyacrylate)IBA 02/2011
1	gamma-cyclodextrinIBA 01/2008
1	CyclodextrinsIBA 01/2008
1	ChlorhexidineIBA 01/2007

Therapy/Procedure

4	Therapeutics 02/2018 - 01/2007